本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ZyVersa Therapeutics, Inc.

0.1475
+0.00704.98%
盤後0.14750.00000.00%16:08 EDT
成交量:27.56萬
成交額:4.07萬
市值:71.88萬
市盈率:-0.02
高:0.1600
開:0.1600
低:0.1300
收:0.1405
資料載入中...
2023/12/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/22

SEC問詢函

Form CORRESP - Correspondence
2023/11/22

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/18

重要事件披露

Form 8-K - Current report
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/04

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/18

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/17

SEC問詢函

Form CORRESP - Correspondence
2023/10/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/06

SEC問詢函

Form CORRESP - Correspondence
2023/09/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/14

重要事件披露

Form 8-K - Current report
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/21

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/18

重要事件披露

Form 8-K - Current report
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals